ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1369–1380 of 2020 project topics
Syndromic Ciliopathy Multi-Gene Screening Kit and Report Automation
A commercial genetic testing kit and automated reporting system that simultaneously screens for multiple syndromic ciliopathies including Usher Syndrome and Senior-Loken Syndrome variants. The product generates revenue through direct laboratory services, white-label partnerships with diagnostic companies, and per-test processing fees.
Genetic Basis of Ciliopathies Click to view more details →
Ciliopathy Carrier Screening Population Health Analytics and Risk Stratification
A population-level health analytics platform that identifies ciliopathy carriers in diverse ethnic groups using targeted SNP panels and provides risk scores for reproductive planning. This B2B SaaS solution monetizes through health system partnerships, insurance company licensing for preventive health programs, and employer wellness platform integrations.
Genetic Basis of Ciliopathies Click to view more details →
Melanoma CDKN2A and CDK4 Risk Testing
Developing CDKN2A and CDK4 testing and surveillance protocols for familial melanoma kindreds for early detection and prevention guidance.
Genetic Risk Stratification in Dermatology Click to view more details →
Basal Cell Nevus Syndrome PTCH1 Molecular Testing
Characterizing PTCH1 pathogenic variants for BCNS diagnosis and developing gorlin-based surveillance programs for jaw cysts and basal cell carcinomas.
Genetic Risk Stratification in Dermatology Click to view more details →
Xeroderma Pigmentosum Gene Panel Testing
Applying XP gene panels covering XPA through XPG and XPV for molecular diagnosis and UV protection and cancer surveillance guidance.
Genetic Risk Stratification in Dermatology Click to view more details →
Skin Cancer Polygenic Risk Score Development
Developing polygenic risk scores for common melanoma and squamous cell carcinoma for identifying genetically high-risk individuals for enhanced surveillance.
Genetic Risk Stratification in Dermatology Click to view more details →
Atypical Mole Syndrome CDKN2A Germline Mutation SaaS Platform
A cloud-based diagnostic platform that identifies CDKN2A germline mutations in patients with atypical mole syndrome to enable early melanoma prevention and targeted surveillance protocols. This SaaS solution generates recurring revenue through subscription licensing to dermatology practices and creates upsell opportunities for integrated patient monitoring dashboards.
Genetic Risk Stratification in Dermatology Click to view more details →
Familial Atypical Multiple Mole and Melanoma Syndrome Predictive Analytics Tool
A machine learning-powered tool that stratifies FAMMM syndrome patients into risk tiers using multi-gene variant analysis and phenotypic data integration for precision oncology workflows. The platform captures high-value clinical data assets and enables premium pricing models for enterprise health system partnerships and insurance risk assessment programs.
Genetic Risk Stratification in Dermatology Click to view more details →
Non-Melanoma Skin Cancer Susceptibility Gene Variant Commerce Platform
An e-commerce enabled testing platform that packages NMSC risk variant identification with personalized prevention product recommendations and digital dermatology consultations. This integrated marketplace generates revenue streams from genetic testing, prevention product sales commissions, and telehealth service fees bundled into tiered membership plans.
Genetic Risk Stratification in Dermatology Click to view more details →
Lynch Syndrome Dermatologic Manifestation Risk Calculator Enterprise Solution
An enterprise software solution that predicts dermatologic cancer manifestations in Lynch syndrome carriers through mismatch repair gene analysis and phenotype correlation engines. The tool creates recurring institutional licensing revenue while enabling cross-selling opportunities with colorectal and endometrial cancer risk platforms to oncology networks.
Genetic Risk Stratification in Dermatology Click to view more details →
Cutaneous Melanoma Somatic Mutation Reporting and Prognostication Service
A specialized laboratory and reporting service that sequences somatic mutations in cutaneous melanomas to generate actionable prognostic and treatment prediction reports for clinicians. This high-margin service model combines laboratory testing fees with value-added clinical decision support subscriptions and institutional data licensing agreements for treatment outcomes research.
Genetic Risk Stratification in Dermatology Click to view more details →
Genodermatosis Risk Screening API and Integration Toolkit
A developer-facing API and white-label toolkit that enables electronic health record systems and dermatology platforms to embed genodermatosis risk screening capabilities directly into clinical workflows. This B2B2C integration model generates developer licensing fees, data analytics subscriptions, and volume-based testing revenue from thousands of distributed clinical endpoints.
Genetic Risk Stratification in Dermatology Click to view more details →